$ZD

J2 GLOBAL, INC.

CIK:0001084048|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Total revenues	$ 286,738	$ 294,803	$ 554,379	$ 567,619
Operating costs and expenses:
Direct costs	45,711	40,663	90,028	81,064
Sales and marketing	122,172	127,044	237,405	239,455
Research, development, and engineering	14,369	14,197	28,006	28,117
General, administrative, and other related costs	47,496	48,794	94,140	91,957
Depreciation and amortization	46,874	50,335	91,752	98,787
Goodwill impairment	54,839	0	54,839	0
Total operating costs and expenses	331,461	281,033	596,170	539,380
Operating (loss) income	(44,723)	13,770	(41,791)	28,239
Interest expense, net	(5,770)	(6,584)	(12,666)	(12,778)
Gain on investments, net	0	4,340	0	4,340
Other (loss) income, net	(586)	(2,402)	102	(3,877)
(Loss) income from continuing operations before income tax expense and income from equity method investment	(51,079)	9,124	(54,355)	15,924
Income tax (expense) benefit	(941)	69	(3,578)	(3,549)
(Loss) income from equity method investment, net of tax	(133)	5,115	5,005	11,745
Net (loss) income from continuing operations	(52,153)	14,308	(52,928)	24,120
Net income from discontinued operations, net of tax	676,614	12,035	699,650	26,462
Net income	$ 624,461	$ 26,343	$ 646,722	$ 50,582
Net (loss) income per common share from continuing operations:
Basic (in dollars per share)	$ (1.43)	$ 0.34	$ (1.43)	$ 0.57
Diluted (in dollars per share)	(1.43)	0.34	(1.43)	0.57
Net income per common share from discontinued operations:
Basic (in dollars per share)	18.60	0.29	18.92	0.63
Diluted (in dollars per share)	18.60	0.29	18.92	0.63
Net income per common share:
Basic (in dollars per share)	17.16	0.63	17.49	1.20
Diluted (in dollars per share)	$ 17.16	$ 0.63	$ 17.49	$ 1.20
Weighted average shares outstanding:
Basic (in shares)	36,381,271	41,732,800	36,985,872	42,143,165
Diluted (in shares)	36,381,271	41,750,114	36,985,872	42,257,116

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities:
Net income	$ 624,461	$ 26,343	$ 646,722	$ 50,582
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			96,656	113,438
Non-cash operating lease costs			3	4,325
Share-based compensation			23,897	21,479
Provision for credit losses on accounts receivable			1,994	1,012
Deferred income taxes, net			(22,542)	(7,320)
Gain on sale of businesses			(860,597)	0
Goodwill impairment	54,839	0	54,839	0
Changes in fair value of contingent consideration			124	(2,318)
Income from equity method investments, net of tax			(5,005)	(11,745)
Gain on investments, net	0	(4,340)	0	(4,340)
Other			3,826	1,701
Decrease (increase) in:
Accounts receivable			204,820	147,417
Prepaid expenses and other current assets			(2,972)	(523)
Other assets			3,480	1,900
Increase (decrease) in:
Accounts payable and accrued expenses			(230,206)	(209,583)
Income taxes payable			204,345	(21,482)
Deferred revenue			7,402	464
Other current liabilities			(7,870)	(7,320)
Net cash provided by operating activities			118,916	77,687
Cash flows from investing activities:
Purchases of property and equipment			(68,126)	(55,752)
Acquisitions, net of cash received			(8,030)	(50,345)
Distribution from equity method investment			0	9,196
Proceeds from sale of equity investments			0	25,250
Proceeds from sale of businesses, net of cash divested			1,134,081	0
Other			(209)	51
Net cash provided by (used in) investing activities			1,057,716	(71,600)
Cash flows from financing activities:
Repurchase of common stock			(173,058)	(68,834)
Issuance of common stock under employee stock purchase plan			3,477	3,751
Deferred payments for acquisitions			(1,162)	(213)
Other			(3,041)	(1,592)
Net cash used in financing activities			(173,784)	(66,888)
Effect of exchange rate changes on cash and cash equivalents			(3,747)	12,180
Net change in cash and cash equivalents			999,101	(48,621)
Cash and cash equivalents at beginning of period			607,011	505,880	$ 505,880
Cash and cash equivalents at beginning of period associated with discontinued operations			33,234	18,380	18,380
Cash and cash equivalents at beginning of period associated with continuing operations			573,777	487,500	487,500
Cash and cash equivalents at end of period	1,606,112	457,259	1,606,112	457,259	607,011
Cash and cash equivalents at end of period associated with discontinued operations	0	18,141	0	18,141	33,234
Cash and cash equivalents at end of period associated with continuing operations	$ 1,606,112	$ 439,118	$ 1,606,112	$ 439,118	$ 573,777

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
ASSETS
Cash and cash equivalents	$ 1,606,112	$ 573,777
Accounts receivable, net of allowances of $6,343 and $8,141, respectively	418,846	623,441
Prepaid expenses and other current assets	59,804	81,964
Current assets - discontinued operations	0	91,217
Total current assets	2,084,762	1,370,399
Long-term investments	99,936	93,228
Property and equipment, net of accumulated depreciation of $419,396 and $382,187, respectively	171,481	162,130
Intangible assets, net	293,773	338,178
Goodwill	1,291,002	1,346,964
Deferred income taxes	5,444	5,107
Other assets	51,629	24,523
Noncurrent assets - discontinued operations	0	322,777
TOTAL ASSETS	3,998,027	3,663,306
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable and accrued expenses	489,554	696,918
Income taxes payable, current	185,637	7,345
Deferred revenue, current	126,974	129,700
Current portion of long-term debt	148,937	148,685
Other current liabilities	12,228	16,089
Current liabilities - discontinued operations	0	76,216
Total current liabilities	963,330	1,074,953
Long-term debt	718,703	717,815
Deferred revenue, noncurrent	5,903	6,518
Liability for uncertain tax positions	19,619	19,733
Deferred income taxes	20,773	41,116
Other noncurrent liabilities	32,241	33,055
Noncurrent liabilities - discontinued operations	0	16,541
TOTAL LIABILITIES	1,760,569	1,909,731
Commitments and contingencies (Note 9)
Preferred stock	0	0
Common stock, $0.01 par value. Authorized 95,000,000; total issued and outstanding 34,962,853 and 38,376,859 shares at June 30, 2026 and December 31, 2025, respectively	350	384
Additional paid-in capital	436,450	472,723
Retained earnings	1,867,704	1,337,542
Accumulated other comprehensive loss	(67,046)	(57,074)
TOTAL STOCKHOLDERS’ EQUITY	2,237,458	1,753,575
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	3,998,027	3,663,306
Series A Preferred Stock
LIABILITIES AND STOCKHOLDERS’ EQUITY
Preferred stock	0	0
Series B Preferred Stock
LIABILITIES AND STOCKHOLDERS’ EQUITY
Preferred stock	$ 0	$ 0